حول الموقع:

اسم النطاق - kyn.ae

عنوان الموقع - Kayan Holding Investment

اذهب إلى الموقع - Kayan Holding Investment

موقع جيو

البلد الموقع - Germany

بلد التسجيل - United States

المدينة / البلدة - Frankfurt am Main

مزود - Akamai Connected Cloud

Site Logo

عنوان IP:

139.144.66.116

خوادم اسم المجال:

ns3.tasjeel.ae ns4.tasjeel.ae

كل السجلات:

☆ kyn.ae. 14400 IN TXT "v=spf1 +a +mx +ip4:139.144.66.116 ~all"
☆ kyn.ae. 14400 IN MX 0 kyn.ae.
☆ kyn.ae. 14400 IN A 139.144.66.116
☆ kyn.ae. 21600 IN NS ns3.tasjeel.ae.
☆ kyn.ae. 21600 IN NS ns4.tasjeel.ae.
☆ kyn.ae. 21600 IN SOA ns3.tasjeel.ae. servers.tasjeel.ae. 2024061201 3600 1800 1209600 86400

Brief facts about kyn:

Kynurenic acid is a product of the normal metabolism of amino acid L-tryptophan. It has been shown that kynurenic acid possesses neuroactive activity. It acts as an antiexcitotoxic and anticonvulsant, most likely through acting as an antagonist at excitatory amino acid receptors. Because of this activity, it may influence important neurophysiological and neuropathological processes. As a result, kynurenic acid has been considered for use in therapy in certain neurobiological disorders. Conversely, increased levels of kynurenic acid have also been linked to certain pathological conditions. Kynurenic acid was discovered in 1853 by the German chemist Justus von Liebig in dog urine, which it was apparently named after. It is formed from L-kynurenine in a reaction catalyzed by the enzyme kynurenine—oxoglutarate transaminase.

Xanthurenic acid - Xanthurenic acid, or xanthurenate, is a metabolic intermediate that accumulates and is excreted by pyridoxine deficient animals after the ingestion of tryptophan. Xanthurenic acid is suspected to be an endogenous agonist for Group II metabotropic glutamate receptors in humans.

Aromatic acids

Kainate receptor antagonists

Quinolinols

AMPA receptor antagonists

Hydroxy acids

Nicotinic antagonists

NMDA receptor antagonists